These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12474678)

  • 1. [Good drug distribution practice and its implementation in drug distribution companies].
    Draksiene G
    Medicina (Kaunas); 2002; 38(5):488-90. PubMed ID: 12474678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Documentation of good distribution practice of medicines and its implementation in Lithuanian drug distribution companies].
    Draksiene G; Petkevicius H; Radziūnas R
    Medicina (Kaunas); 2003; 39 Suppl 2():4-8. PubMed ID: 14617851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P; Pantano D; Gennari CG; Casiraghi A
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
    de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Community requirements relating to drugs derived from human blood and plasma].
    Brunko P
    Ann Pharm Fr; 1994; 52(2):89-98. PubMed ID: 7944184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory aspects of stability testing in Europe.
    Matthews BR
    Drug Dev Ind Pharm; 1999 Jul; 25(7):831-56. PubMed ID: 10459489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liability for pharmaceutical products: a difficult attempt at harmonisation.
    Rougé-Maillart C; Jousset N; Penneau M
    Med Law; 2004; 23(2):393-401. PubMed ID: 15270478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inspections: the international regulatory view.
    Turner JL
    PDA J Pharm Sci Technol; 1994; 48(4):180-1. PubMed ID: 7804815
    [No Abstract]   [Full Text] [Related]  

  • 12. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liberalization and integration of drug distribution in the EU 28 and Norway.
    Písek J; Pícha K
    Ceska Slov Farm; 2018; 67(1):14-24. PubMed ID: 30157663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory status of medicinal products for human beings in the European Union. The role of generic products.
    Minghetti P
    Pharmacol Res; 1996; 34(1-2):3-7. PubMed ID: 8981548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal products in the European Union--between harmonization and divergence.
    Lojko N
    Med Law; 2010 Mar; 29(1):61-76. PubMed ID: 22457998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standards imposed by the pharmacopoeia on drugs].
    Büchi J
    Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies.
    Taylor RB; Shakoor O; Behrens RH; Everard M; Low AS; Wangboonskul J; Reid RG; Kolawole JA
    Lancet; 2001 Jun; 357(9272):1933-6. PubMed ID: 11425415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.